Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Investigating Preoperative Bintrafusp Alfa in Operable Urothelial Carcinoma of the Bladder

NCT04878250 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT04878250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04878250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Investigating Preoperative Bintrafusp Alfa in Operable Urothelial Carcinoma of the Bladder
Lead sponsor
Queen Mary University of London
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2021
Completion date
January 31, 2025
Enrollment
49 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, transitional cell carcinoma